Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 2/20 | 0.35 |
| ▸ | CTSL | P07711 | 2/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 5/20 | 0.32 |
| ▸ | MPL | P40238 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21036878 | 0.95 | CTSV (0.35) | CTSVCTSLGPR3DHODHRARB | |
| SCHEMBL21037138 | 0.92 | PDK2 (0.31) | — | |
| SCHEMBL26431165 | 0.92 | PDK2 (0.30) | — | |
| SCHEMBL21037378 | 0.91 | PDK2 (0.32) | — | |
| SCHEMBL26431162 | 0.89 | — | — | |
| SCHEMBL26431141 | 0.89 | PDK2 (0.31) | — | |
| SCHEMBL21037508 | 0.88 | PDK2 (0.31) | — | |
| SCHEMBL26431176 | 0.88 | ICMT (0.33) | — | |
| SCHEMBL26431151 | 0.87 | ICMT (0.33) | — | |
| SCHEMBL21037363 | 0.87 | PDK2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639339-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| US-11639339-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| US-20210024481-A1 | MATERIALS FOR ORGANIC ELETROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-01-28 | — | — | US | disclosed |
| WO-2019101835-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024481-A1 | MATERIALS FOR ORGANIC ELETROLUMINESCENT DEVICES | GLB1, EFNA1, L1CAM | CTSV 609/4885CTSL 1047/4885GPR3 3709/4885 |
| US-11639339-B2 | Materials for organic electroluminescent devices | L1CAM, EFNA1, EPCAM | CTSV 2130/4885CTSL 4344/4885GPR3 4042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.